Review





Similar Products

adjuvant cfa  (Chondrex Inc)
99
Chondrex Inc adjuvant cfa
Adjuvant Cfa, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adjuvant cfa/product/Chondrex Inc
Average 99 stars, based on 1 article reviews
adjuvant cfa - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
adjuvant cfa  (InvivoGen)
95
InvivoGen adjuvant cfa
Male mice were immunized with myelin oligodendrocyte glycoprotein (MOG) emulsified in <t>complete</t> <t>Freund’s</t> adjuvant <t>(CFA)</t> at DPI (days post immunization) 0 or with CFA (control). (A) Mechanical allodynia was evaluated weekly using a von Frey test over a period of 30 days. Experimental autoimmune encephalomyelitis (EAE)-immunized animals have significantly decreased withdrawal threshold, indicating the development of neuropathic pain-like symptoms. (B) Clinical scores were evaluated daily to assess paresis until DPI 30. 50% of the EAE-immunized mice developed paresis. (C) Ataxia was measured using a composite scoring system, and non-PTX EAE immunization led to ataxia development. Data is presented as mean ± SEM, ****p < 0.0001. Data were analyzed using GraphPad Prism 10.0. Normality tests determined the use of appropriate statistical analyses. von Frey and ataxia data were analyzed by two-way ANOVA (α = 0.05) with model as the between-subjects factor and time as the repeated measure. Paresis severity was evaluated using the area under the curve (AUC) across all measurement days, with significance assessed by an unpaired t-test. P values less than 0.05 were considered significant.
Adjuvant Cfa, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adjuvant cfa/product/InvivoGen
Average 95 stars, based on 1 article reviews
adjuvant cfa - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
complete freund s adjuvant cfa  (Chondrex Inc)
99
Chondrex Inc complete freund s adjuvant cfa
Male mice were immunized with myelin oligodendrocyte glycoprotein (MOG) emulsified in <t>complete</t> <t>Freund’s</t> adjuvant <t>(CFA)</t> at DPI (days post immunization) 0 or with CFA (control). (A) Mechanical allodynia was evaluated weekly using a von Frey test over a period of 30 days. Experimental autoimmune encephalomyelitis (EAE)-immunized animals have significantly decreased withdrawal threshold, indicating the development of neuropathic pain-like symptoms. (B) Clinical scores were evaluated daily to assess paresis until DPI 30. 50% of the EAE-immunized mice developed paresis. (C) Ataxia was measured using a composite scoring system, and non-PTX EAE immunization led to ataxia development. Data is presented as mean ± SEM, ****p < 0.0001. Data were analyzed using GraphPad Prism 10.0. Normality tests determined the use of appropriate statistical analyses. von Frey and ataxia data were analyzed by two-way ANOVA (α = 0.05) with model as the between-subjects factor and time as the repeated measure. Paresis severity was evaluated using the area under the curve (AUC) across all measurement days, with significance assessed by an unpaired t-test. P values less than 0.05 were considered significant.
Complete Freund S Adjuvant Cfa, supplied by Chondrex Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/complete freund s adjuvant cfa/product/Chondrex Inc
Average 99 stars, based on 1 article reviews
complete freund s adjuvant cfa - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

Image Search Results


Male mice were immunized with myelin oligodendrocyte glycoprotein (MOG) emulsified in complete Freund’s adjuvant (CFA) at DPI (days post immunization) 0 or with CFA (control). (A) Mechanical allodynia was evaluated weekly using a von Frey test over a period of 30 days. Experimental autoimmune encephalomyelitis (EAE)-immunized animals have significantly decreased withdrawal threshold, indicating the development of neuropathic pain-like symptoms. (B) Clinical scores were evaluated daily to assess paresis until DPI 30. 50% of the EAE-immunized mice developed paresis. (C) Ataxia was measured using a composite scoring system, and non-PTX EAE immunization led to ataxia development. Data is presented as mean ± SEM, ****p < 0.0001. Data were analyzed using GraphPad Prism 10.0. Normality tests determined the use of appropriate statistical analyses. von Frey and ataxia data were analyzed by two-way ANOVA (α = 0.05) with model as the between-subjects factor and time as the repeated measure. Paresis severity was evaluated using the area under the curve (AUC) across all measurement days, with significance assessed by an unpaired t-test. P values less than 0.05 were considered significant.

Journal: Bio-protocol

Article Title: Advancing EAE Modeling: Establishment of a Non-Pertussis Immunization Protocol for Multiple Sclerosis

doi: 10.21769/BioProtoc.5589

Figure Lengend Snippet: Male mice were immunized with myelin oligodendrocyte glycoprotein (MOG) emulsified in complete Freund’s adjuvant (CFA) at DPI (days post immunization) 0 or with CFA (control). (A) Mechanical allodynia was evaluated weekly using a von Frey test over a period of 30 days. Experimental autoimmune encephalomyelitis (EAE)-immunized animals have significantly decreased withdrawal threshold, indicating the development of neuropathic pain-like symptoms. (B) Clinical scores were evaluated daily to assess paresis until DPI 30. 50% of the EAE-immunized mice developed paresis. (C) Ataxia was measured using a composite scoring system, and non-PTX EAE immunization led to ataxia development. Data is presented as mean ± SEM, ****p < 0.0001. Data were analyzed using GraphPad Prism 10.0. Normality tests determined the use of appropriate statistical analyses. von Frey and ataxia data were analyzed by two-way ANOVA (α = 0.05) with model as the between-subjects factor and time as the repeated measure. Paresis severity was evaluated using the area under the curve (AUC) across all measurement days, with significance assessed by an unpaired t-test. P values less than 0.05 were considered significant.

Article Snippet: Complete Freund’s Adjuvant (CFA) (InvivoGen, catalog number: vac-cfa-10) 3.

Techniques: Adjuvant, Control